<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/44CDAA37-A000-4CC6-B623-C2C78D4F916B"><gtr:id>44CDAA37-A000-4CC6-B623-C2C78D4F916B</gtr:id><gtr:name>MRC Virology Unit</gtr:name><gtr:address><gtr:line1>Glasgow University</gtr:line1><gtr:line2>Church Street</gtr:line2><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G11 5JR</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/44CDAA37-A000-4CC6-B623-C2C78D4F916B"><gtr:id>44CDAA37-A000-4CC6-B623-C2C78D4F916B</gtr:id><gtr:name>MRC Virology Unit</gtr:name><gtr:address><gtr:line1>Glasgow University</gtr:line1><gtr:line2>Church Street</gtr:line2><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G11 5JR</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/5A22724B-63AF-4DFE-9686-0640873858F7"><gtr:id>5A22724B-63AF-4DFE-9686-0640873858F7</gtr:id><gtr:firstName>Chris</gtr:firstName><gtr:surname>Preston</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U130169964"><gtr:id>B046359C-1708-4019-9B55-29D6BA45638D</gtr:id><gtr:title>Mode of action of human cytomegalovirus protein pp71</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U130169964</gtr:grantReference><gtr:abstractText>Human cytomegalovirus (HCMV) causes a variety of human diseases. The majority of the population in Western society harbour the virus without noticeable symptoms, but HCMV is a serious problem in situations where an individuals immunity is damaged. This is a problem for organ transplant recipients, where the virus multiplies in the donated organ and causes rejection, and in AIDS patients, where HCMV infection can result in a serious, widespread infection. If contracted by mothers during pregnancy, HCMV can infect the foetus and cause major permanent damage. The drug ganciclovir is active against HCMV, but it must be administered continuously to prevent the virus from resuming infection. Long term ganciclovir therapy is undesirable due to side effects.||We are trying to understand how HCMV starts its infection of the host, and have concentrated our efforts on one part of the virus that is important at this early stage. The work is currently a detailed study in the laboratory, using specialised cells. It is hoped that by understanding in detail how the infection begins we will discover a basis for the production of new drugs that prevent HCMV from having its often devastating effects.</gtr:abstractText><gtr:technicalSummary>Human cytomegalovirus (HCMV) is a large DNA-containing virus and a member of the herpesvirus family. Infection with HCMV causes a variety of human diseases. In normal adults, infection is usually asymptomatic although the virus persists in the host in a latent state after primary infection. In immunosuppressed individuals, however, HCMV causes severe disease affecting multiple organs, due either to primary infection or to reactivation of latent virus. HCMV infection is a major problem for organ transplant recipients, often causing rejection, and in AIDS patients, resulting in widespread serious disease. Malformation of the foetus as a result of maternal infection with HCMV is the most prevalent single cause of birth defects in the developed world. Antiviral therapy with ganciclovir is reasonably effective provided the drug is administered continuously, but disease reappears upon withdrawal of treatment. Unfortunately, long term therapy is associated with toxic side effects. The pathogenesis of HCMV is poorly understood at the molecular level. In common with other herpesviruses, HCMV regulates expression of its genome in a coordinated manner. The first genes to be transcribed are classed as immediate early (IE), representing a small subset of the total viral gene content. The IE gene products include regulators of transcription which combine to ensure the expression of the remaining genes. Our research is concerned with a protein constituent of the virus particle, pp71, that stimulates IE transcription and is important in initiating the infection process that ultimately results in cell death and virus production. We aim to understand at the molecular level how pp71 activates IE gene expression. We have shown that pp71 stimulates HCMV IE transcription by disrupting a complex between two cellular proteins, Daxx and ATRX. In this way, the virus overcomes a host cell intrinsic defence against infection, thereby permitting virus replication and cell death. A detailed understanding the interaction between pp71, Daxx and ATRX will aid the development of antiviral agents that can block infection, and in addition may provide information relevant to the problem of HCMV latency. An unexpected spin-off from the work has already arisen: pp71 antagonises host responses that shut off expression of the HSV-1 genome, and this may assist in the development of new viral vectors for human gene therapy.</gtr:technicalSummary><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2002-08-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1845007</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>B50872DE-5043-4C9C-924F-4C89FA483338</gtr:id><gtr:title>Interaction of the human cytomegalovirus particle with the host cell induces hypoxia-inducible factor 1 alpha.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6edfda6ae70caa6ca31e9ac717318a60"><gtr:id>6edfda6ae70caa6ca31e9ac717318a60</gtr:id><gtr:otherNames>McFarlane S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn><gtr:outcomeId>tZvEL13Qij4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3ACFF0D2-1260-44F2-A2E4-32386655FDAC</gtr:id><gtr:title>Reactivation of expression from quiescent herpes simplex virus type 1 genomes in the absence of immediate-early protein ICP0.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64cecba718a3b3eda6b9c70c2b1aba91"><gtr:id>64cecba718a3b3eda6b9c70c2b1aba91</gtr:id><gtr:otherNames>Preston CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>EF0DF1F2BD2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20A791DD-0059-43CE-BDD6-B96350082B63</gtr:id><gtr:title>Herpes simplex virus type 1 genomes are associated with ND10 nuclear substructures in quiescently infected human fibroblasts.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb4eb49c160fb66c372318dbd0fb5edb"><gtr:id>bb4eb49c160fb66c372318dbd0fb5edb</gtr:id><gtr:otherNames>Everett RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>03A137A79B6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3609B781-AA90-4840-A168-7D96815B358B</gtr:id><gtr:title>Induction of cellular stress overcomes the requirement of herpes simplex virus type 1 for immediate-early protein ICP0 and reactivates expression from quiescent viral genomes.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64cecba718a3b3eda6b9c70c2b1aba91"><gtr:id>64cecba718a3b3eda6b9c70c2b1aba91</gtr:id><gtr:otherNames>Preston CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>5662361DDCE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58D03B75-C294-4528-8BEB-5FA2F6538A34</gtr:id><gtr:title>Early induction of autophagy in human fibroblasts after infection with human cytomegalovirus or herpes simplex virus 1.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6edfda6ae70caa6ca31e9ac717318a60"><gtr:id>6edfda6ae70caa6ca31e9ac717318a60</gtr:id><gtr:otherNames>McFarlane S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>JYAtrnSzMWm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62BD5B64-C753-4931-AB03-1D70C1F61681</gtr:id><gtr:title>Encyclopedia of Virology</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d84ba4286cf25475718302139b2d6c75"><gtr:id>d84ba4286cf25475718302139b2d6c75</gtr:id><gtr:otherNames>Preston C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:isbn>9780123744104</gtr:isbn><gtr:outcomeId>E1B93E5B897</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88DB8849-007B-4347-865D-348D6E52F20E</gtr:id><gtr:title>Role of the cellular protein hDaxx in human cytomegalovirus immediate-early gene expression.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64cecba718a3b3eda6b9c70c2b1aba91"><gtr:id>64cecba718a3b3eda6b9c70c2b1aba91</gtr:id><gtr:otherNames>Preston CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>316E21E0B4C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>428526DE-55AA-4E28-BFA9-AC50079C7CF4</gtr:id><gtr:title>Human cytomegalovirus protein pp71 displaces the chromatin-associated factor ATRX from nuclear domain 10 at early stages of infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0174e08fa5793d8eb306670cc319622b"><gtr:id>0174e08fa5793d8eb306670cc319622b</gtr:id><gtr:otherNames>Lukashchuk V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>8FCB6A5E8C5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>379D3C4C-A949-4751-8994-404A53B197D5</gtr:id><gtr:title>An investigation of herpes simplex virus promoter activity compatible with latency establishment reveals VP16-independent activation of immediate-early promoters in sensory neurones.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81859d54f369edee64d02adfc915c974"><gtr:id>81859d54f369edee64d02adfc915c974</gtr:id><gtr:otherNames>Proen?a JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>Lzzg1fr5ZTd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA81D675-C4FE-417D-B148-3DA02B05BC20</gtr:id><gtr:title>Human cytomegalovirus immediate early gene expression in the osteosarcoma line U2OS is repressed by the cell protein ATRX.</gtr:title><gtr:parentPublicationTitle>Virus research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6edfda6ae70caa6ca31e9ac717318a60"><gtr:id>6edfda6ae70caa6ca31e9ac717318a60</gtr:id><gtr:otherNames>McFarlane S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0168-1702</gtr:issn><gtr:outcomeId>pv6FHkBvRqS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EB2A076-090D-4718-A2A2-B205C6A2ACCE</gtr:id><gtr:title>The UL25 gene product of herpes simplex virus type 1 is involved in uncoating of the viral genome.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3dff8febf35500e4e4ad59809cdcc9c8"><gtr:id>3dff8febf35500e4e4ad59809cdcc9c8</gtr:id><gtr:otherNames>Preston VG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>1663AF30F3C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F44AF94-F975-4A70-B4DA-71FA45615849</gtr:id><gtr:title>Histone modifications associated with herpes simplex virus type 1 genomes during quiescence and following ICP0-mediated de-repression.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61f7be11eb20322df302018f747b8094"><gtr:id>61f7be11eb20322df302018f747b8094</gtr:id><gtr:otherNames>Coleman HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>2069F192781</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CC94F8C-D46B-49C0-A892-405DCCBB712E</gtr:id><gtr:title>CD8(+) T-cell attenuation of cutaneous herpes simplex virus infection reduces the average viral copy number of the ensuing latent infection.</gtr:title><gtr:parentPublicationTitle>Immunology and cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4686bf61af55f5464b0ab6654f10aecd"><gtr:id>4686bf61af55f5464b0ab6654f10aecd</gtr:id><gtr:otherNames>Wakim LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0818-9641</gtr:issn><gtr:outcomeId>1407E60D4AA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D6BDE6D-99D8-46E4-83FB-DBDC4757E48B</gtr:id><gtr:title>Antivirals reduce the formation of key Alzheimer's disease molecules in cell cultures acutely infected with herpes simplex virus type 1.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e7b41c5ed64d653d46527dd890aa53e3"><gtr:id>e7b41c5ed64d653d46527dd890aa53e3</gtr:id><gtr:otherNames>Wozniak MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>JrZ57rPsZFS</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U130169964</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>